3:06 PM
Aug 09, 2018
 |  BC Extra  |  Company News

CVS earns less off rebates than the Street thought

CVS Health Corp. (NYSE:CVS) reported lower-than-expected contribution of retained rebates to its 2Q18 earnings and drew closer to completing its acquisition of Aetna Inc. (NYSE:AET) -- a move expected to cut its healthcare costs.

CVS revealed that it expects to bring in retained rebates of $300 million for the year, or about 3% of annual adjusted EPS.

Mizuho Americas Healthcare Services Analyst Ann Hynes told BioCentury she had estimated that rebates account for...

Read the full 345 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >